483
Shilpa Medicare LimitedShilpa Medicare Limited – FDA 483, Sep 6, 2019
Record Details
Shilpa Medicare Limited in Polepally, India, a manufacturer of human drug products, was cited for deficiencies in its quality control laboratory. The inspection revealed that the firm did not follow its written stability testing program, leading to sample analyses exceeding allowed timelines. Additionally, insanitary conditions were observed for QC lab instruments and apparatus, contributing to a high rate of out-of-specification results.
View Company Profile
ID · 454b93df-428c-4c44-a718-2062133d8ced
Other documents for Shilpa Medicare Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.